Moreover, we show that fpr1–/– mice and neutrophil-depleted C57BL/6 WT mice are protected from bleomycin-induced pulmonary fibrosis, highlighting the potential therapeutic benefit of targeting FPR-1 or neutrophils in the fibrotic lung. The gene discussed is FPR1; the disease is pulmonary fibrosis.